x 

0 Activities
0 Activities
    • No Saved Activities
Page 7 of 7
Results 451 - 479 of 479
IL-derm-case2
When to Switch? Biologically Experienced Psoriasis Patients
IL-derm-case1
Innovator or Biosimilar for a Patient with Psoriasis
IL-fund-case4
Interchangeability and Pharmacy-Level Substitution
IL-fund-case3
FDA Criteria: Biosimilar Approval, Manufacturing, & Naming
IL-fund-case2
What is the Difference Between a Biosimilar and a Generic?
IL-fund-case1
What is a Biologic?
No image set
New Strides in EGFR Inhibition for Non–Small Cell Lung Cancer
No image set
Pete - Work-Up of a Patient with Right Upper Lobe Mass and Metastases
No image set
Carl - High Suspicion of Lung Cancer: Setting the Stage with a Good Biopsy
biosims-green5
Are You Ready to Use Biosimilars in Your Practice?
No image set
Radiologic Features of IPF
No image set
Gwen: A lawyer with a history of MI has a dry cough and trouble with stairs
No image set
Elizabeth: Loves the outdoors but bothered by persistent cough and GERD
No image set
Toni: Too tired to continue teaching and experiencing painful heartburn
No image set
Individualizing Patient Education in Treatment Choice: Practical Strategies
biosims-full8
Biosimilars in Clinical Practice: Interchangeability and Extrapolation
No image set
Individualizing Patient Education in Treatment Choice: Practical Strategies
No image set
Addressing Common Barriers to Adherence
No image set
Discovering New Drugs for IPF
No image set
Biomarkers for IPF
No image set
New Trends in IPF
No image set
New Trends in IPF
No image set
Treatment Dilemmas Case Study: Harrison
No image set
A New Era in IPF: Trials and Treatments
No image set
Highlights from ATS 2014: Discussions on Clinical Trial Data
No image set
Highlights from ATS 2014: Update on Predicting Clinical Progression
No image set
Highlights from ATS 2014: Top Line Clinical Trial Results - ASCEND, INPULSIS, and PANTHER
No image set
Exciting IPF Developments from 2015 ERS
No image set
Exciting Developments from 2015 CHEST
Page 7 of 7

Search